Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 1651 AL 1665

Chronic motor performance following different traumatic brain injury severity-A systematic review

Corrigan F, Wee IC, Collins-Praino LE.

Front Neurol. 2023 May 11;14:1180353. doi: 10.3389/fneur.2023.1180353. eCollection 2023.

Patient Reported Outcome Measures for Salivary Function: A Systematic Review

Gulati A, Kidane J, Chang JL.

Laryngoscope. 2023 Aug;133(8):1796-1805. doi: 10.1002/lary.30550. Epub 2023 Jan 6.

α-Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid-A Systematic Review and Meta-Analysis

Grossauer A, Hemicker G, Krismer F, Peball M, Djamshidian A, Poewe W, Seppi K, Heim B.

Mov Disord Clin Pract. 2023 Mar 15;10(5):737-747. doi: 10.1002/mdc3.13710. eCollection 2023 May.

Dopamine 2 agonists for the management of type 2 diabetes: a systematic review and meta-analysis

Dereje B, Nardos A.

J Diabetes Metab Disord. 2023 May 12;22(2):931-943. doi: 10.1007/s40200-023-01230-4. eCollection 2023 Dec.

Paradoxical kinesia may no longer be a paradox waiting for 100 years to be unraveled

Melo-Thomas L, Schwarting RKW.

Rev Neurosci. 2023 Mar 20;34(7):775-799. doi: 10.1515/revneuro-2023-0010. Print 2023 Oct 26.

Paraoxonases at the Heart of Neurological Disorders

Khalaf FK, Connolly J, Khatib-Shahidi B, Albehadili A, Tassavvor I, Ranabothu M, Eid N, Dube P, Khouri SJ, Malhotra D, Haller ST, Kennedy DJ.

Int J Mol Sci. 2023 Apr 7;24(8):6881. doi: 10.3390/ijms24086881.

Ginsenosides can target brain-derived neurotrophic factor to improve Parkinson's disease

Ding Y, Botchway BOA, Zhang Y, Liu X.

Food Funct. 2023 Jun 19;14(12):5537-5550. doi: 10.1039/d2fo03484k.

An Apple a Day to Keep the Parkinson's Disease Doctor Away?

Bloem BR, Post E, Hall DA.

Ann Neurol. 2023 Apr;93(4):681-685. doi: 10.1002/ana.26612. Epub 2023 Feb 9.

The old second messenger cAMP teams up with novel cell death mechanisms: potential translational therapeutical benefit for Alzheimer's disease and Parkinson's disease

Zhang T, Luu MDA, Dolga AM, Eisel ULM, Schmidt M.

Front Physiol. 2023 Jun 19;14:1207280. doi: 10.3389/fphys.2023.1207280. eCollection 2023.

Parkinson's disease and gut microbiota: from clinical to mechanistic and therapeutic studies

Zhang X, Tang B, Guo J.

Transl Neurodegener. 2023 Dec 15;12(1):59. doi: 10.1186/s40035-023-00392-8.

Sex Differences in the Level of Homocysteine in Alzheimer's Disease and Parkinson's Disease Patients: A Meta-Analysis

Nguyen VP, Collins AE, Hickey JP, Pfeifer JA, Kalisch BE.

Brain Sci. 2023 Jan 15;13(1):153. doi: 10.3390/brainsci13010153.

The brain-first vs. body-first model of Parkinson's disease with comparison to alternative models

Borghammer P.

J Neural Transm (Vienna). 2023 Jun;130(6):737-753. doi: 10.1007/s00702-023-02633-6. Epub 2023 Apr 16.

Parkinson's Disease: From Genetics and Epigenetics to Treatment, a miRNA-Based Strategy

Paccosi E, Proietti-De-Santis L.

Int J Mol Sci. 2023 May 31;24(11):9547. doi: 10.3390/ijms24119547.

Acupuncture Improves Sleep Disorders and Depression among Patients with Parkinson's Disease: A Meta-Analysis

Hsu WT, Hsu CM, Hung SC, Hung SY.

Healthcare (Basel). 2023 Jul 17;11(14):2042. doi: 10.3390/healthcare11142042.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias